Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities

Posted on | Posted on John Murphy | Leave a Comment on Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities

The I-TECH Randomized Clinical Trial Authors: Steven Chee Loon Lim, MRCP1; Chee Peng Hor, MSc2,3; Kim Heng Tay, MRCP4; et al JAMA Intern Med. Published online February 18, 2022. doi:10.1001/jamainternmed.2022.0189 Key Points Question  Does adding ivermectin, an inexpensive and widely available antiparasitic drug, to the standard of care reduce the risk of severe disease in patients with COVID-19 and comorbidities? Findings  In this open-label randomized clinical trial […]

Mystery of the missing workers? Long COVID a big piece of the puzzle

Posted on | Posted on John Murphy | Leave a Comment on Mystery of the missing workers? Long COVID a big piece of the puzzle

Authors: Michael E. Kanell, The Atlanta Journal-Constitution Feb 19, 2022 She suffered cardiac arrest twice and was in the hospital for three months, then came home to more than a year of kidney problems and intermittent brain fog, tingling in her hands, numbness in her right foot and a need for oxygen after even modest […]

Gastrointestinal perforation secondary to COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Gastrointestinal perforation secondary to COVID-19

Case reports and literature review Authors: Reem J. Al Argan, MBBS, SB-Med, SF-Endo, FACE, ECNU,∗Safi G. Alqatari, MBBS, MRCPI, MMedSc, CFP (Rheum), Abir H. Al Said, MBBS, SB-Med, CFP (Pulmo.), Raed M. Alsulaiman, MBBS, SB-Med, Abdulsalam Noor, MBBS, SB-Med, ArBIM, SF-Nephro, Lameyaa A. Al Sheekh, MD, SB-med, and Feda’a H. Al Beladi, MD Abstract Introduction: Corona virus disease-2019 (COVID-19) presents […]

Abdominal Pain and Diffuse Colitis Following COVID-19 Infection: Report of a Case

Posted on | Posted on John Murphy | Leave a Comment on Abdominal Pain and Diffuse Colitis Following COVID-19 Infection: Report of a Case

Authors: Rouzbeh ShadidiAsilaSetarehMahmoodiaAmirZamaniaAzadehHakakzadehbcElenaJamalid International Journal of Surgery Case Reports Volume 8, November 2021, 106473 Highlights • Patients with COVID-19 sometimes presents with GI symptoms in addition to respiratory symptoms.• Detecting RNA of SARS-CoV-2 in the stool specimen of the patient with COVD-19 has raised the concern of fecal-oral transmission of the virus.• Invasion of the virus […]

HOW COVID-19 AFFECTS THE GUT: SCIENTISTS UNCOVER A RARE SIDE EFFECT

Posted on | Posted on John Murphy | Leave a Comment on HOW COVID-19 AFFECTS THE GUT: SCIENTISTS UNCOVER A RARE SIDE EFFECT

Authors: published on The Conversation by Vincent Ho at Western Sydney University. Although we might think of Covid-19 as a respiratory disease, we know it involves the gut. In fact, SARS-CoV-2, the virus that causes Covid-19, enters our cells by latching onto protein receptors called ACE2. And the greatest numbers of ACE2 receptors are in the cells that line the gut. […]

Pfizer BioNTech Covid Vaccine and Ovarian cysts – a phase IV clinical study of CDC and FDA data

Posted on | Posted on John Murphy | Leave a Comment on Pfizer BioNTech Covid Vaccine and Ovarian cysts – a phase IV clinical study of CDC and FDA data

Summary: Ovarian cysts is found among people who get Pfizer BioNTech Covid Vaccine, especially for people who are 30-39 old, and after 30 days of getting the vaccine. The phase IV clinical study analyzes which people get Pfizer BioNTech Covid Vaccine and have Ovarian cysts. It is created by eHealthMe based on reports of 286,220 […]

Long COVID Could Be Linked to the Effects of SARS-CoV-2 on the Vagus Nerve

Posted on | Posted on John Murphy | Leave a Comment on Long COVID Could Be Linked to the Effects of SARS-CoV-2 on the Vagus Nerve

Authors: EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES FEBRUARY 11, 2022 New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022, Lisbon, April 23-26) suggests that many of the symptoms connected to post-COVID syndrome (PCC, also known as long COVID) could be linked to the effect of the […]

Management of urticaria in COVID-19 patients: A systematic review

Posted on | Posted on John Murphy | Leave a Comment on Management of urticaria in COVID-19 patients: A systematic review

Authors: Eyad Abuelgasim,Ann Christine Modaragamage Dona,Rajan Singh Sondh,Amer Harky First published: 28 September 2020 https://doi.org/10.1111/dth.14328 Abstract The global pandemic COVID-19 has resulted in significant global morbidity, mortality and increased healthcare demands. There is now emerging evidence of patients experiencing urticaria. We sought to systematically review current evidence, critique the literature, and present our findings. Allowing PRISMA […]

Famotidine clinical trial shows COVID-19 symptom reduction

Posted on | Posted on John Murphy | Leave a Comment on Famotidine clinical trial shows COVID-19 symptom reduction

Authors:  Dagnia Zeidlickis, Vice President, Communications | zeidlick@cshl.edu | 516-367-8455 A high dose of famotidine, commonly known as Pepcid®, was found to have beneficial effects in adult patients with coronavirus disease 2019 (COVID-19), according to results of an outpatient clinical trial. Patients who took famotidine in this trial experienced a decrease of inflammation within the body and reported earlier […]